Sight Sciences (SGHT) Gets a Buy from Lake Street
TipRanks (Tue, 3-Mar 9:45 AM ET)
Underappreciated Growth in TearCare and OMNI Drives Buy Rating and $8 Target for Sight Sciences
TipRanks (Mon, 2-Mar 8:05 AM ET)
Sight Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
Globe Newswire (Wed, 18-Feb 4:05 PM ET)
Globe Newswire (Tue, 13-Jan 7:05 AM ET)
Market Chameleon (Fri, 17-Oct 7:14 AM ET)
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
Sight Sciences trades on the NASDAQ stock market under the symbol SGHT.
As of March 3, 2026, SGHT stock price declined to $5.34 with 239,916 million shares trading.
SGHT has a beta of 2.02, meaning it tends to be more sensitive to market movements. SGHT has a correlation of 0.19 to the broad based SPY ETF.
SGHT has a market cap of $282.34 million. This is considered a Small Cap stock.
Last quarter Sight Sciences reported $20 million in Revenue and -$.16 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.10.
In the last 3 years, SGHT traded as high as $11.20 and as low as $1.04.
The top ETF exchange traded funds that SGHT belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.
SGHT has outperformed the market in the last year with a return of +101.5%, while the SPY ETF gained +15.9%. However, in the most recent history, SGHT shares have underperformed the stock market with its stock returning -35.7% in the last 3 month period and -0.4% for the last 2 week period, while SPY has returned +0.2% and -0.1%, respectively.
SGHT support price is $5.34 and resistance is $5.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SGHT shares will trade within this expected range on the day.
